Ausgabe 3/2007
Inhalt (13 Artikel)
ADOPT: Lessons from Comparison of Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy
Hannele Yki-Jarvinen
NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes
Elisabetta Bugianesi, Ester Vanni, Giulio Marchesini
Nonalcoholic fatty liver disease and cardiovascular disease risk
Roger K. Schindhelm, Michaela Diamant, Robert J. Heine
Antihypertensive agents, insulin sensitivity, and new-onset diabetes
Pantelis A. Sarafidis, Samy I. McFarlane, George L. Bakris
Prevention of type 2 diabetes: An update
Amal Farag, Jocelyne Karam, John Nicasio, Samy I. McFarlane
Hypertension in people with diabetes and the metabolic syndrome: Pathophysiologic insights and therapeutic update
Sudha Ganne, Surender K. Arora, Olena Dotsenko, Samy I. McFarlane, Adam Whaley-Connell
Effects of hyperglycemia and hyperinsulinemia on the tissue factor pathway of blood coagulation
Guenther Boden, A. Koneti Rao